Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yurong Lai

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 22, 2022
Human and nonclinical disposition of [<sup>14</sup>C]bictegravir, a potent integrase strand-transfer inhibitor for the treatment of HIV-1 infectionRaju Subramanian, John Ling, Jianhong Wang, et al.
Clinical and Translational Science|April 15, 2019
Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy VolunteersSook Wah Yee, Marilyn M Giacomini, Hong Shen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 2, 2021
Endogenous Plasma Kynurenic Acid in Human: A Newly Discovered Biomarker for Drug-Drug Interactions Involving Organic Anion Transporter 1 and 3 InhibitionJennifer Tang, Hong Shen, Xiaofeng Zhao, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 22, 2013
Model-based approaches to predict drug-drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyondHugh A Barton, Yurong Lai, Theunis C Goosen, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 1, 2007
In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placentaRajgopal Govindarajan, Aimee H Bakken, Kelly L Hudkins, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinomaYuan Chen, Xiulong Song, Leila Valanejad, et al.
The AAPS Journal|October 12, 2017
Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Clearance and Liver Partitioning of OATP and OCT Substrates in Cynomolgus MonkeysBridget L Morse, Jamus G MacGuire, Anthony M Marino, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 6, 2015
Evaluation of rosuvastatin as an organic anion transporting polypeptide (OATP) probe substrate: in vitro transport and in vivo disposition in cynomolgus monkeysHong Shen, Hong Su, Tongtong Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 31, 2012
A novel relay method for determining low-clearance valuesLi Di, Patrick Trapa, R Scott Obach, et al.
Analytical Biochemistry|June 19, 2008
Absolute quantification of multidrug resistance-associated protein 2 (MRP2/ABCC2) using liquid chromatography tandem mass spectrometryNa Li, Olga V Nemirovskiy, Yiqun Zhang, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 22, 2022
Human and nonclinical disposition of [<sup>14</sup>C]bictegravir, a potent integrase strand-transfer inhibitor for the treatment of HIV-1 infectionRaju Subramanian, John Ling, Jianhong Wang, et al.
Clinical and Translational Science|April 15, 2019
Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy VolunteersSook Wah Yee, Marilyn M Giacomini, Hong Shen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 2, 2021
Endogenous Plasma Kynurenic Acid in Human: A Newly Discovered Biomarker for Drug-Drug Interactions Involving Organic Anion Transporter 1 and 3 InhibitionJennifer Tang, Hong Shen, Xiaofeng Zhao, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 22, 2013
Model-based approaches to predict drug-drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyondHugh A Barton, Yurong Lai, Theunis C Goosen, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 1, 2007
In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placentaRajgopal Govindarajan, Aimee H Bakken, Kelly L Hudkins, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinomaYuan Chen, Xiulong Song, Leila Valanejad, et al.
The AAPS Journal|October 12, 2017
Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Clearance and Liver Partitioning of OATP and OCT Substrates in Cynomolgus MonkeysBridget L Morse, Jamus G MacGuire, Anthony M Marino, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 6, 2015
Evaluation of rosuvastatin as an organic anion transporting polypeptide (OATP) probe substrate: in vitro transport and in vivo disposition in cynomolgus monkeysHong Shen, Hong Su, Tongtong Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 31, 2012
A novel relay method for determining low-clearance valuesLi Di, Patrick Trapa, R Scott Obach, et al.
Analytical Biochemistry|June 19, 2008
Absolute quantification of multidrug resistance-associated protein 2 (MRP2/ABCC2) using liquid chromatography tandem mass spectrometryNa Li, Olga V Nemirovskiy, Yiqun Zhang, et al.
Pageof 14